Download presentation
Presentation is loading. Please wait.
Published byDoris Stone Modified over 6 years ago
1
VcR-CVAD Induction Chemotherapy Followed by Maintenance Rituximab Produces Durable Remissions in Mantle Cell Lymphoma: A Wisconsin Oncology Network Study Julie E. Chang, Lakeesha L. Carmichael, KyungMann Kim, Christopher Peterson, David T. Yang, Anne M. Traynor, Jae E. Werndli, Michael S. Huie, Thomas A. McFarland, Michael Volk, Jules Blank, Natalie S. Callander, Walter L. Longo, Brad S. Kahl Clinical Lymphoma, Myeloma and Leukemia Volume 18, Issue 1, Pages e61-e67 (January 2018) DOI: /j.clml Copyright © 2017 Elsevier Inc. Terms and Conditions
2
Figure 1 Progression-free Survival. The Single Event at 8 Years was Death From Lung Cancer (Mantle Cell Lymphoma in Ongoing Remission) Clinical Lymphoma, Myeloma and Leukemia , e61-e67DOI: ( /j.clml ) Copyright © 2017 Elsevier Inc. Terms and Conditions
Similar presentations
© 2024 SlidePlayer.com Inc.
All rights reserved.